Table 5.
Models | C-statistics (95% CI) | △C-statistics (95% CI) | P value |
---|---|---|---|
C-ACS | 0.643 (0.600–0.685) | – | – |
C-ACS + leukocytes | 0.676 (0.626–0.726) | 0.033 (0.012–0.055) | 0.003 |
C-ACS + neutrophils | 0.695 (0.646–0.744) | 0.052 (0.026–0.078) | < 0.001 |
C-ACS + lymphocytes | 0.688 (0.640–0.736) | 0.046 (− 0.005 to 0.085) | 0.045 |
C-ACS + monocytes | 0.663 (0.615–0.711) | 0.020 (0.002–0.039) | 0.029 |
C-ACS + eosinophils | 0.686 (0.640–0.733) | 0.044(0.021–0.070) | < 0.001 |
C-ACS + basophils | 0.670 (0.623–0.718) | 0.028(0.004–0.053) | < 0.026 |
C-ACS + NMLR | 0.722 (0.675–0.768) | 0.079 (0.042–0.115) | < 0.001 |
C-ACS + NLR | 0.720 (0.674–0.767) | 0.077 (0.041–0.112) | < 0.001 |
C-ACS + MLR | 0.712 (0.669–0.754) | 0.069 (0.027–0.107) | < 0.001 |
C-ACS + ELR | 0.686 (0.639–0.734) | 0.044(0.017–0.066) | < 0.001 |
△C-statistics indicated the difference in C-statistic between C-ACS models and models additionally including leukocytes, neutrophils, lymphocytes, monocytes, eosinophils, basophils, NMLR, NLR, MLR, or ELR
C-ACS Canada Acute Coronary Syndrome Risk Score, NMLR neutrophil-plus-monocyte-to-lymphocyte ratio, NLR neutrophil-to-lymphocyte ratio, MLR monocyte-to-lymphocyte ratio, ELR eosinophil-to-leukocyte ratio